Chemed Corp: Form 10-Q for the period ended Jun 30, 2015
Filed with the SEC on Jul 31, 2015 and accepted by EDGAR at Jul 31, 2015, 07:31 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2015-04-01 to 2015-06-30 | $381.9m | us-gaap:SalesRevenueNet |
| Revenue | 6 months2015-01-01 to 2015-06-30 | $758.6m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2015-04-01 to 2015-06-30 | $270.7m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2015-01-01 to 2015-06-30 | $539.5m | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2015-04-01 to 2015-06-30 | $58.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2015-01-01 to 2015-06-30 | $116.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2015-04-01 to 2015-06-30 | $44.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2015-01-01 to 2015-06-30 | $85.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2015-04-01 to 2015-06-30 | $969.0k | us-gaap:InterestExpense |
| Interest expense | 6 months2015-01-01 to 2015-06-30 | $1.9m | us-gaap:InterestExpense |
| Income tax | 3 months2015-04-01 to 2015-06-30 | $17.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2015-01-01 to 2015-06-30 | $32.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2015-04-01 to 2015-06-30 | $27.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2015-01-01 to 2015-06-30 | $51.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2015-04-01 to 2015-06-30 | $1.55 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2015-01-01 to 2015-06-30 | $2.96 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2015-04-01 to 2015-06-30 | $1.60 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2015-01-01 to 2015-06-30 | $3.05 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2015-04-01 to 2015-06-30 | 17,419,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2015-01-01 to 2015-06-30 | 17,419,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2015-01-01 to 2015-06-30 | $69.6m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 6 months2015-01-01 to 2015-06-30 | $18.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2015-01-01 to 2015-06-30 | $7.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2015-01-01 to 2015-06-30 | $29.8m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2015-06-30 | $32.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-06-30 | $190.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2015-06-30 | $885.3m | us-gaap:Assets |
| Current liabilities | At period end2015-06-30 | $161.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2015-06-30 | $407.5m | us-gaap:Liabilities |
| Long-term debt | At period end2015-06-30 | $152.5m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2015-06-30 | $7.5m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2015-06-30 | $477.8m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2015-06-30 | 16,919,487 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001157523-15-002664. Last ingested by Listed: Oct 29, 2026, 09:14 ET. Listed shows no prices and gives no investment advice.